13 Facts About Stanozolol

Stanozolol has mostly been discontinued, and remains available in only a few countries.

Stanozolol is one of the AAS commonly used as performance-enhancing drugs and is banned from use in sports competition under the auspices of the International Association of Athletics Federations and many other sporting bodies.

Stanozolol has been used with some success to treat venous insufficiency.

Stanozolol is used for physique- and performance-enhancing purposes by competitive athletes, bodybuilders, and powerlifters.

Stanozolol is not a substrate for 5a-reductase as it is already 5a-reduced, and so is not potentiated in so-called "androgenic" tissues like the skin, hair follicles, and prostate gland.

Related searches

Stanozolol has high oral bioavailability, due to the presence of its C17a alkyl group and the resistance to gastrointestinal and liver metabolism that it results in.

Stanozolol is metabolized in the liver, ultimately becoming glucuronide and sulfate conjugates.

Stanozolol, known as 17a-methyl-2'H-androst-2-eno[3,2-c]pyrazol-17ß-ol, is a synthetic 17a-alkylated androstane steroid and a derivative of 5a-dihydrotestosterone with a methyl group at the C17a position and a pyrazole ring attached to the A ring of the steroid nucleus.

Stanozolol is subject to extensive hepatic biotransformation by a variety of enzymatic pathways.

In 1962, Stanozolol was brought to market in the US by Winthrop under the tradename "Winstrol" and in Europe by Winthrop's partner, Bayer, under the name "Stromba".

Stanozolol is still used long-term to reduce the frequency of severity of attacks.

Stanozolol is especially widely used by the athletes from post-Soviet countries.

Stanozolol has been investigated in the treatment of a number of dermatological conditions including urticaria, hereditary angioedema, Raynaud's phenomenon, cryofibrinogenemia, and lipodermatosclerosis.